Version 2 2020-04-14, 13:56Version 2 2020-04-14, 13:56
Version 1 2020-04-14, 13:55Version 1 2020-04-14, 13:55
dataset
posted on 2020-04-14, 13:56authored byEPA's Center for Computational Toxicology and Exposure
<p>These are the supplemental files for TOXSCI manuscript
19-0578 entitled, “Respirometric Screening and Characterization of
Mitochondrial Toxicants Within the ToxCast Phase I and II Chemical Libraries”:</p>
<p> </p><p>Supplemental Figure 1 shows the
median fold inhibition for basal (A) and maximal (B) respiration phases for
nine test chemicals represented as 18 internally-duplicated samples used to
measure intra-assay reproducibility (red dashed lines show threshold used to
define bioactivity).</p><p><br></p><p>Supplemental Figure 2 shows the
temporal dose-response plots (median % initial respiration ± mad) for all 243
chemicals tested in Tier 2 RSA screening. </p><p><br></p><p>Supplemental Figure 3 shows the
temporal dose-response plots (median % initial respiration ± mad) for all 149
ETCi chemicals tested in the EFA.</p><p><br></p><p>Supplemental Table 1 lists five
QC metrics calculated using DMSO, fenpyroximate, and 2,4-dinitrophenol controls
used to evaluate RSA performance.</p><p><br></p><p>Supplemental Table 2 lists the
1,042 ToxCast chemicals tested in this study with activity calls for each
testing tier, proposed mechanism of mitochondrial toxicity for RSA-actives and
the inhibited respiratory complex(es) for putative ETC inhibitors. Maximal test
concentrations are in µM excepting those values exceeding 200, which are in
µg/µL.</p><p><br></p><p>Supplemental File A delineates
how the respirometric screening assay protocol differs from the commonly-used
mitochondrial stress assay protocol and provides a rationale for those
differences.</p><p></p>